MedTrace Logo

Use and Safety of the LUTONIX® Drug Coated Balloon Catheter in Arteries of the Lower Extremity

NCT02043951 · Status: TERMINATED · Type: OBSERVATIONAL · Enrollment: 59

Last updated 2016-07-13

No results posted yet for this study

Summary

The registry will enroll patients with claudication or critical limb ischemia and angiographically significant lesion(s) in arteries of the lower extremity. Subjects will be treated with the Lutonix® Drug Coated Balloon Catheter for approved indications according to the current country-specific Instructions for Use (IFU) and followed clinically for 1 year.

Conditions

Interventions

DEVICE

Lutonix Drug Coated Balloon Catheter

Sponsors & Collaborators

  • C. R. Bard

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2014-01-31
Primary Completion
2015-12-31
Completion
2016-01-31

Countries

  • Canada
  • Malaysia
  • New Zealand

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02043951 on ClinicalTrials.gov